Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Analyst Rating Guide

News

Back

Repare Therapeutics Q1 EPS $0.30 Beats $0.02 Estimate, Sales $52.40M Beat $38.40M Estimate

Author: Benzinga Newsdesk | May 07, 2024 05:01pm

Repare Therapeutics (NASDAQ:RPTX) reported quarterly earnings of $0.30 per share which beat the analyst consensus estimate of $0.02 by 1400 percent. This is a 136.14 percent increase over losses of $(0.83) per share from the same period last year. The company reported quarterly sales of $52.40 million which beat the analyst consensus estimate of $38.40 million by 36.47 percent. This is a 822.93 percent increase over sales of $5.68 million the same period last year.

Posted In: RPTX